CompletedNot Applicable

Ovarian Reserve Following Medical Therapy in Patients With Endometriosis

Italy44 participantsStarted 2020-07-19

Plain-language summary

This study aims to investigate whether there is an effect on ovarian reserve from medical therapy for endometriosis. Although the therapeutic efficacy of medical hormone therapy on ovarian endometriosis has been proven in many scientific studies, none of these has shown an effect on ovarian reserve. The aim of this study is to investigate whether there is a difference in ovarian reserve as measured by biochemical and ultrasound parameters before and after therapy.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical and ultrasound diagnosis of ovarian endometriosis without indication for surgery * Age between 18 and 40 years * Patients desiring pregnancy * Informed consent obtained Exclusion Criteria: * Endocrinological disorders (including thyroid dysfunction, hyperprolactinaemia and Cushing's syndrome) * Previous ovarian surgery * Suspected cyst malignancy

What they're measuring

Ovarian reserve in patients with ovarian endometriosis

Timeframe: Through study completion, an average of 4 years

Trial details

NCT IDNCT06799754

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-31

View on ClinicalTrials.gov More Endometriosis trials